This country profile provides an overview of Botswana’s progress in reaching those in need of mass NTD treatment based on 2016 data.
NTD mass treatment coverage index: 2/100
Overall rank: 37th
These recommendations were given to heads of state at the African Union summit in January 2017 as part of the ALMA Scorecard for Accountability and Action.
- Given the good soil-transmitted helminths (STH) preventive chemotherapy (PC) coverage achieved, implement PC for schistosomiasis alongside STH, at least for school-aged children.
- Increase budget allocation for neglected tropical diseases at the national level.
- Provide timely data to the Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN) to enable monitoring and planning.
Botswana does not require mass treatment for lymphatic filariasis.
Botswana does not require mass treatment for onchocerciasis.
Treatment coverage remained the same at 0% in 2015 and 2016.
⬆️ Treatment coverage increased from 0% in 2015 to 29% in 2016.
Botswana does not require mass treatment for trachoma.